Get Enquiry


Application Details :

A potentially effective weapon in the fight against HIV and other STIs is the microbicide. These products are intended to be applied to vaginal surfaces in order to stop infections from spreading during intercourse. Microbicides, as opposed to condoms, provide a covert and feminine-controlled kind of protection, which makes them especially helpful in circumstances where condom use may be difficult to negotiate. Pre-exposure prophylaxis, or PrEP, is one kind of microbicide that is intended to be taken prior to pathogen exposure. Antiretroviral medications, which can stop HIV from replicating if it gets inside the body, are often found in PrEP microbicides. These microbicides lower the risk of HIV infection by forming a barrier of protection against the virus when given topically to the rectal or vaginal mucosa. Post-exposure prophylaxis (PEP), which is administered following possible pathogen exposure, is another kind of microbicide. PEP microbicides are designed to be used during a particular window of time following intercourse in order to stop the spread of infection. These microbicides function by swiftly neutralizing or eliminating the virus before it has a chance to penetrate the body. Microbicides come in a variety of formulations; some are made to be gels, creams, foams, or films. A number of considerations, including user acceptability, stability, and convenience of use, influence the formulation choice. For instance, films and foams have the benefit of being less dirty, yet gels and creams are frequently chosen for their ease of application. Ensuring the safety and efficacy of microbicides is a difficulty in the development process. Microbicides need to be safe for everyday use since people who are very susceptible to infection frequently use them. They must also be effective against multiple pathogens, not just one kind. In an ongoing effort to create safe and reliable microbicides, researchers are putting their products through a rigorous testing process. The development of microbicides holds promise for enabling people—especially women—to defend themselves against STIs independently of their partners' involvement. Microbicides are a useful addition to the current STI prevention toolset since they provide a female-controlled means of prevention. In order to improve public health outcomes and lessen the worldwide burden of STIs, more research and development in this area is promising.